ARCHIVES

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years

May 1, 1987

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

UICC Congress Urges World Commitment To Cancer Prevention.

July 14, 2006

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014